Tacstick 3 Capsule contains Tacrolimus 3 mg, a high-potency calcineurin inhibitor and immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This capsule works by suppressing T-lymphocyte activation via calcineurin inhibition, reducing immune-mediated damage to transplanted organs. It is suitable for patients requiring higher-dose immunosuppression under strict medical supervision.
Clinically, Tacstick 3 Capsule is used in renal, hepatic, and cardiac transplant regimens, often in combination with corticosteroids and other immunosuppressants, to maintain graft function and reduce rejection risk.
The capsule ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it ideal for hospitals, transplant centers, specialty pharmacies, and clinics managing post-transplant immunosuppressive therapy.
Common side effects include headache, tremors, nausea, diarrhea, insomnia, and mild infections. Rare but serious adverse effects include nephrotoxicity, hypertension, neurotoxicity, hyperglycemia, and severe infections.
Tacstick 3 Capsule is indicated for the prevention of organ transplant rejection in renal, hepatic, or cardiac transplant recipients. It is also used under specialist supervision for management of selected autoimmune disorders.
Use Tacstick 3 Capsule strictly under medical supervision. Regular monitoring of kidney function, blood pressure, drug levels, and infection signs is essential. Inform your doctor about any history of kidney or liver disease, diabetes, or concurrent medications. Avoid live vaccines and seek immediate medical attention if persistent fever, unusual bleeding, or neurological symptoms occur.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.